What is the management plan for a pregnant woman with a single fetus in a twin gestation diagnosed with severe fetal growth restriction (FGR) indicated by a cerebroplacental ratio (CPR) of 0.7?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of sFGR Twin with CPR 0.7

A CPR of 0.7 in a twin with selective fetal growth restriction (sFGR) indicates brain-sparing physiology and warrants intensified surveillance with weekly umbilical artery Doppler, weekly cardiotocography after viability, and delivery planning based on umbilical artery Doppler findings rather than CPR alone. 1

Understanding CPR 0.7 in Context

A CPR of 0.7 represents an abnormal cerebroplacental ratio (typically defined as <1.0 or below the 5th percentile depending on gestational age), indicating cerebral vasodilation in response to placental insufficiency—the "brain-sparing effect." 2 This physiologic adaptation occurs when the fetus redistributes blood flow to protect vital organs (brain, heart, adrenals) even when placental function is only mildly impaired. 2

However, current SMFM guidelines explicitly state that CPR should NOT be used for routine clinical management decisions in FGR. 1 The available evidence shows large variations in sensitivity and specificity, and CPR has not been proven to improve outcomes over umbilical artery Doppler alone in clinical trials. 1

Immediate Assessment Required

Umbilical Artery Doppler - The Critical Decision Point

The umbilical artery Doppler determines your entire management pathway: 1

  • Normal diastolic flow: Weekly umbilical artery Doppler surveillance 1
  • Decreased diastolic flow (elevated PI/RI >95th percentile): Weekly umbilical artery Doppler, plan delivery at 37 weeks 1
  • Absent end-diastolic velocity (AEDV): Doppler 2-3 times per week, delivery at 33-34 weeks 1
  • Reversed end-diastolic velocity (REDV): Hospitalization, CTG 1-2 times daily, delivery at 30-32 weeks 1

Cardiotocography Surveillance

  • Weekly CTG after viability if umbilical artery shows normal or decreased diastolic flow 1, 3
  • Increase to 1-2 times daily if AEDV or REDV detected 1, 3
  • CTG abnormalities in FGR almost invariably precede ductus venosus abnormalities after 32 weeks 3

Growth and Amniotic Fluid Monitoring

  • Serial growth assessments every 2-3 weeks to monitor progression 2
  • Amniotic fluid volume assessment as oligohydramnios significantly increases perinatal risk and may necessitate earlier delivery 4, 5

Delivery Timing Algorithm

Base delivery timing on umbilical artery Doppler findings, NOT on CPR: 1

If EFW <3rd Percentile (Severe FGR):

  • Deliver at 37 weeks regardless of Doppler findings 1

If EFW 3rd-10th Percentile:

  • Normal umbilical artery Doppler: Deliver at 38-39 weeks 1
  • Decreased diastolic flow: Deliver at 37 weeks 1
  • AEDV: Deliver at 33-34 weeks 1
  • REDV: Deliver at 30-32 weeks 1

Mode of Delivery Considerations

  • Cesarean delivery should be strongly considered if AEDV or REDV present, based on the entire clinical scenario 1
  • Induction of labor is reasonable if umbilical artery end-diastolic flow is present with continuous CTG monitoring 4, 3
  • FGR fetuses have 75-95% risk of requiring cesarean delivery for intrapartum fetal heart rate abnormalities, especially with oligohydramnios 4

Essential Perinatal Interventions

  • Antenatal corticosteroids if delivery anticipated before 33 6/7 weeks or between 34 0/7-36 6/7 weeks 1
  • Magnesium sulfate for neuroprotection if delivery <32 weeks 1
  • Monitor for maternal hypertension as it is present in 50-70% of early-onset FGR cases and independently predicts poor outcomes 1

Critical Pitfalls to Avoid

  • Do not use CPR alone to time delivery—it lacks validation for clinical decision-making despite its physiologic significance 1, 2
  • Do not rely solely on CTG without Doppler integration—umbilical artery Doppler is the primary surveillance tool 1, 3
  • Do not delay delivery when umbilical artery Doppler shows AEDV or REDV—these findings mandate specific gestational age delivery windows 1
  • Do not miss oligohydramnios—severe oligohydramnios with FGR is an independent indication for delivery consideration 4, 5

Twin-Specific Considerations

While CPR has shown utility in singleton pregnancies, evidence in twin gestations is limited. 6 One study found that abnormal CPR at 20-24 weeks in twins did not predict third-trimester FGR (OR 1.00,95% CI 0.56-1.79), suggesting FGR in twins results from multiple factors beyond blood flow redistribution. 6 This reinforces the guideline recommendation to avoid using CPR for routine clinical management decisions. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Abnormal Cerebroplacental Ratio as a Marker of Fetal Compromise

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cardiotocography Monitoring Guidelines for Fetal Growth Restriction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Intrauterine Growth Restriction at 38 Weeks with Severe Oligohydramnios

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cerebroplacental doppler ratio and perinatal outcome in late-onset foetal growth restriction.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2022

Research

The cerebroplacental ratio and prediction of fetal growth restriction in twin pregnancies.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.